234 win agent login Arcadium Lithium Announces Shareholder Approval of Proposed Rio Tinto Transaction and Provides Regulatory Update

Federal prosecutors seek records from company that deployed AI weapons scanner on NYC subway NEW YORK (AP) — Federal investigators in New York are seeking records from the manufacturer of an AI-powered weapons scanner that was briefly deployed this summer in New York City’s subway system. Jake Offenhartz, The Associated Press Nov 26, 2024 2:37 PM Nov 26, 2024 2:50 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message FILE - Gun detection machines are tested at the Fulton Street transit station, July 26, 2024, in New York. (AP Photo/John Minchillo, File) NEW YORK (AP) — Federal investigators in New York are seeking records from the manufacturer of an AI-powered weapons scanner that was briefly deployed this summer in New York City’s subway system. The tech company, Evolv, revealed in a public filing that it “received a voluntary document request from the U.S. Attorney’s Office of the Southern District of New York” on Nov. 1. It was unclear what the request was seeking. The U.S. Attorney’s Office in Manhattan declined to comment on the request, which was first reported by the Daily News. In an emailed statement, a spokesperson for Evolv said the company was “pleased to cooperate with all government agencies and regulators who request information from our company.” The Massachusetts-based tech company, whose scanners have also been used at sports stadiums and schools, has faced allegations of misconduct. Last month, Evolv’s board of directors fired its chief executive following an internal investigation that found certain sales had been “subject to extra-contractual terms and conditions.” On Tuesday, the company announced it had resolved a previous probe launched by the Federal Trade Commission last year over allegations of deceptive marketing practices. The company is also under separate investigation by the Securities and Exchange Commission. Despite the legal and regulatory scrutiny, New York City Mayor Eric Adams announced a pilot program this summer to bring a handful of scanners to the city's subways to deter gun violence. The initiative drew immediate criticism from civil liberties groups who said the searches were unconstitutional, along with questions about its efficacy. In October, the city revealed the scanners did not detect any passengers with firearms — but falsely alerted more than 100 times. At the time, a spokesperson for the New York Police Department said it was still “evaluating the outcome of the pilot” and had not entered into any contract with Evolv. Jake Offenhartz, The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message Get your daily Victoria news briefing Email Sign Up More Science News Drake makes another legal move against Universal over Kendrick Lamar diss track 'Not Like Us' Nov 26, 2024 1:20 PM Surveillance tech advances by Biden could aid in Trump's promised crackdown on immigration Nov 26, 2024 1:16 PM Canadian companies excited about AI but slow to adopt it: AI tech leaders Nov 26, 2024 12:50 PM

Analytic Partners Placed Highest for Ability to Execute and Furthest for Completeness of Vision MIAMI , Nov. 22, 2024 /PRNewswire/ -- Analytic Partners, the Commercial Intelligence company for insights-driven brands, today announced it has been recognized as a Leader in the inaugural Gartner® Magic QuadrantTM for Marketing Mix Modeling (MMM) Solutions. Analytic Partners is positioned highest in Ability to Execute and furthest in Completeness of Vision. "We believe our position as a Leader underscores our dedication to our customers and our ongoing commitment to innovation," said Nancy Smith , President and CEO of Analytic Partners. "We appreciate the extensive research Gartner has done in guiding our industry forward. This recognition, we feel, highlights the critical role Commercial Analytics plays in delivering forward-looking decisioning for lasting, meaningful growth." Elevating Insights Beyond MMM and MTA Analytic Partners' longstanding commitment to deliver insights and solutions extends well beyond Multi-Touch Attribution (MTA) and MMM. Analytic Partners' Commercial Analytics solution integrates all factors driving performance outcomes – including finance, supply chain and other enterprise functions. This holistic, company-wide approach provides a forward-looking decisioning framework that brands rely on to measure both short-term and long-term impact, ensuring sustained growth. GPS Enterprise: A Powerful Platform for Enabling Growth Powered by the GPS Enterprise platform, Commercial Analytics combines data science and technology to deliver actionable insights that enable brands to make proactive, forward-looking commercial decisions. This end-to-end platform, informed by ROI Genome intelligence, ensures streamlined data management, application of advanced analytics and multi-objective optimizations to help brands meet their growth goals. Recognition extends to Gartner Critical Capabilities Report for MMM Solutions The recognition also extends beyond the Magic QuadrantTM. In the accompanying Critical Capabilities report for MMM Solutions, Analytic Partners received the highest scores across all 8 Use Cases, including: Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high, and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables businesses to get the most from market analysis in alignment with your unique business and technology needs. To read the full Magic QuadrantTM report, access a complimentary copy here . Gartner, Magic Quadrant for Marketing Mix Modeling Solutions, Matt Wakeman , David Walters , Joseph Enever , Weicong Zhao , November 19, 2024 GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. About Analytic Partners Analytic Partners is the leader in Commercial Analytics, providing adaptive solutions for deeper business understanding, right-time planning and optimization for marketing and beyond. We turn data into expertise so our customers can create powerful connections with their customers and achieve commercial success. For more information, visit analyticpartners.com . Photo - https://mma.prnewswire.com/media/2565668/Analytic_Partners.jpg View original content to download multimedia: https://www.prnewswire.com/news-releases/analytic-partners-recognized-as-a-leader-in-inaugural-gartner-magic-quadrant-for-marketing-mix-modeling-solutions-302314467.html SOURCE Analytic Partners

Lewandowski joins Ronaldo and Messi in Champions League 100-goal club. Haaland nets 2 but City drawsBRD hosts stakeholder engagement workshop to accelerate clean energy access in Rwanda

Grant of Restricted Stock Units and Warrants to Employees in GenmabShamed David Coote at centre of betting probe after discussing booking player BEFORE game & saying ‘I hope you backed’Biden administration to loan $6.6B to EV maker Rivian to build Georgia factory that automaker paused

The co-founders of two of Canada's top artificial intelligence firms say companies in the country are buzzing with excitement around the technology but turning that enthusiasm into products and tools takes too long. Cohere co-founder Nick Frosst says he has grown used to being approached by Canadian firms wanting to work with AI but they're slow to actually implement the technology. Frosst says it is hard to pinpoint where that lack of urgency comes from but he thinks part of it is embedded in Canada's culture. Nicole Janssen, the co-founder of AltaML, has had a similar experience. She says it takes 18 months for companies reaching out to her business to commit to using AI and then another 18 months to start doing something with it. She says the danger in this long lead time is that people get tired of devoting energy and resources to projects that are not immediately giving them a return on their investment and then this work falls to the wayside.Odisha govt starts preparations for President Murmu’s 5-day visit to state from Dec 3Security First Insurance partners with Embark MGA to enter the New Home Builder insurance channel with the launch of an innovative HO5 Product in Florida

NonePLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023 . The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc.

Pep Guardiola’s side at least avoided the indignity of a sixth successive defeat in all competitions but alarm bells continue to ring at the Etihad Stadium after a dramatic late capitulation. A double from Erling Haaland – the first from the penalty spot – and a deflected effort from Ilkay Gundogan, all in the space of nine minutes either side of the break, looked to have ensured a return to winning ways. Yet Guardiola was left with his head in hands as Feyenoord roared back in the last 15 minutes with goals from Anis Hadj Moussa, Sergio Gimenez and David Hancko, two of them after Josko Gvardiol errors. City almost snatched a late winner when Jack Grealish hit the woodwork but there was no masking another dispiriting result. It was hardly the preparation City wanted for Sunday’s crunch trip to Liverpool, and the Feyenoord fans took great delight in rubbing that fact in. They sung the club anthem they share with Liverpool, You’ll Never Walk Alone, and chanted the name of their former manager Arne Slot, the current Reds boss. Guardiola arrived at the ground with a cut on the bridge of his nose and, once again, his side have been struck a nasty blow. Despite not being at their best, they had dominated early on against what seemed limited Dutch opposition. They threatened when a Gundogan shot was deflected wide and Haaland then went close to opening the scoring when he turned a header onto the post. Feyenoord goalkeeper Timon Wellenreuther gifted City another chance when he passed straight to Bernardo Silva but Grealish’s fierce volley struck team-mate Phil Foden. Foden forced a save from Wellenreuther but City had a moment of alarm when Igor Paixao got behind the defence only to shoot tamely at Ederson. Nathan Ake missed the target with a header but some luck finally went City’s way just before the break when Quinten Timber, brother of Arsenal’s Jurrien, was harshly adjudged to have fouled Haaland. The Norwegian rammed home the resulting spot-kick and City returned re-energised for the second period. They won a corner when a Matheus Nunes shot was turned behind and Gundogan fired the hosts’ second – albeit with aid of a deflection – with a firm volley from the edge of the box. City turned up the heat and claimed their third soon after as Gundogan released Nunes with a long ball and his low cross was turned into the net by a sliding Haaland. 44' ⚽️ Man City 1-0 Feyenoord50' ⚽️ Man City 2-0 Feyenoord53' ⚽️ Man City 3-0 Feyenoord75' ⚽️ Man City 3-1 Feyenoord82' ⚽️ Man City 3-2 Feyenoord89' ⚽️ Man City 3-3 Feyenoord 🤯🤯🤯 #UCL — UEFA Champions League (@ChampionsLeague) November 26, 2024 It seemed City were heading for a morale-lifting victory but a couple of Gvardiol errors changed the script. The Croatian, who had a torrid time in Saturday’s 4-0 thrashing by Tottenham, first horribly misplaced a backpass and allowed Moussa to nip in and round Ederson. Ordinarily that 75th-minute reply would have been a mere consolation and City would close out the game, but Gvardiol had another moment to forget eight minutes from time. Again he gave the ball away and Feyenoord pounced. The ball was lofted into the box and Jordan Lotomba fired a shot that glanced the post and deflected across goal, where Gimenez chested in. Ederson then blundered as he raced out of his area and was beaten by Paixao, who crossed for Hancko to head into an empty net. Amid some moments of unrest in the crowd, when objects were thrown, City tried to rally in stoppage time. Grealish had an effort deflected onto the bar but the hosts had to settle for a draw.Stock market today: Wall Street rises at the start of a holiday-shortened week

OTURN Showcases Advanced CNC Solutions at Bauma CHINA 2024NoneSLTL Group To Showcase Latest Laser Technologies At IMTEX 2025 In Bengaluru

Jonah Goldberg: What if most Americans aren't bitterly divided?NEW YORK , Dec. 19, 2024 /PRNewswire/ -- Standard Motor Products, Inc. (SMP) is pleased to announce that it released a total of 2,367 new part numbers in 2024, including introductions from SMP's Vehicle Control and Temperature Control divisions. New coverage for late-model import and domestic vehicles was added across all powertrains, including advanced internal combustion engine (ICE), hybrid and electric. Standard's ongoing commitment to advanced internal combustion engine (ICE) technology is evident in this year's releases. The Standard® Gas Fuel Injection program expands with the introduction of ten new Direct Injection High-Pressure Fuel Pumps covering 2.5 million import and domestic vehicles, and GDI High-Pressure Fuel Pump Kits were added for GM cars and SUVs. Additionally, 31 Gasoline Direct Injection (GDI) and Multi-Port Fuel Injection (MFI) Fuel Injectors were added. Standard's Turbocharger program expanded with the addition of several new Turbocharger Kits, as well as an array of related components such as Intercoolers, Bypass Valves, Wastegate Solenoids and more. Thirteen new Oil Filter Housing Assemblies and Kits were introduced with coverage for Chrysler, Ford, BMW, Toyota, Audi, Volvo and more. Emission control systems are increasingly complex, and Standard® has them covered more than ever before, with extensive additions to its evaporative emission, exhaust gas recirculation, and crankcase emission programs. Multiple Canister Purge Solenoids and Valves have been introduced, as well as over 30 EGR Tubes, Engine Crankcase Breather Hoses for nearly 14 million vehicles, and Fuel Vapor Canisters for popular Ford, Toyota, Chrysler, Lexus and Toyota vehicles. Multiple powertrain-neutral categories are forecasted to grow, and Standard® has released extensive coverage in these categories. A total of 72 ABS Speed Sensors were added to Standard's product line this year, and Advanced Driver Assistance Systems (ADAS) categories also saw substantial increases, with the addition of 53 new Park Assist Cameras and 76 Park Assist Sensors covering millions of late-model vehicles. Electronic Parking Brake Actuators were also released for over 13 million vehicles including the 2023-19 Mazda 3, 2024-23 Ford Heavy Duty trucks and Jeep SUVs through 2024. Four Seasons® introduced new coverage which included Hose Assemblies for millions of import and domestic vehicles. New Compressors were also added, with coverage for popular vehicles like the 2023-22and 2023-21 Hyundai Elantra. Coverage for hybrid and electric vehicles expands with Electric Coolant Pumps for the 2022-16 Lexus RX450h, 2019-17 Toyota Highlander, 2019-18 Toyota Prius C and more. Four Seasons' Air Door Actuator program has expanded, with dozens of new numbers, offering coverage for Ford, Chrysler, Subaru, Infiniti, Toyota and more. Additional categories that see expansion include Water Inlets, Water Outlets, Evaporators, Heater Cores and more. Jack Ramsey , Senior Vice President of Sales and Marketing, SMP, stated, "We are proud of the expansion displayed by both divisions in 2024. Our distribution partners continually look to SMP for the highest-quality components along with expansive coverage, and we are committed to exceeding their expectations." All new applications are listed in the catalogs found at StandardBrand.com and 4S.com , and in electronic catalog providers. About SMP With over 100 years in business, Standard Motor Products, Inc. is a leading independent manufacturer and distributor of premium replacement parts in the automotive aftermarket and a custom-engineered solutions provider to vehicle and equipment manufacturers in diverse non-aftermarket end markets. SMP sells its products primarily to retailers, warehouse distributors, original equipment manufacturers and original equipment service part operations in the United States , Canada , Europe , Asia , Mexico and other Latin America countries. For more information, download the SMP ® Parts App or visit SMPcorp.com . View original content to download multimedia: https://www.prnewswire.com/news-releases/standard-motor-products-releases-2-367-new-numbers-in-2024--302336665.html SOURCE Standard Motor Products, Inc.

Washington Post abruptly ‘removes’ politics editor Dan Eggen after Trump win: report

Atria Investments Inc Takes $330,000 Position in Lantheus Holdings, Inc. (NASDAQ:LNTH)None